Investors finally get a glimpse of Genetic Technologies Limited (GENE) volume hitting the figure of 1.19 million.

Genetic Technologies Limited (NASDAQ: GENE) kicked off on May 23, 2023, at the price of $1.10, down -0.48% from the previous trading day. During the day, the shares moved up to $1.18 and dropped to $1.00 before settling in for the closing price of $1.03. Over the past 52 weeks, GENE has traded in a range of $0.83-$2.40.

Annual sales at Healthcare sector company grew by 67.30% over the past five years. While this was happening, its average annual earnings per share was recorded 7.20%. With a float of $13.09 million, this company’s outstanding shares have now reached $15.39 million.

Let’s look at the performance matrix of the company that is accounted for 52 employees. In terms of profitability, gross margin is -35.00, operating margin of -136.67, and the pretax margin is -140.71.

Genetic Technologies Limited (GENE) Latest Financial update

This company achieved a net margin of -104.95 while generating a return on equity of -37.57. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 7.20% per share during the next fiscal year.

Genetic Technologies Limited (NASDAQ: GENE) Trading Performance Indicators

Take a look at Genetic Technologies Limited’s (GENE) current performance indicators. Last quarter, stock had a quick ratio of 2.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.11.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.37

Technical Analysis of Genetic Technologies Limited (GENE)

Genetic Technologies Limited (NASDAQ: GENE) saw its 5-day average volume 0.35 million, a negative change from its year-to-date volume of 1.48 million. As of the previous 9 days, the stock’s Stochastic %D was 51.38%. Additionally, its Average True Range was 0.07.

During the past 100 days, Genetic Technologies Limited’s (GENE) raw stochastic average was set at 12.74%, which indicates a significant decrease from 44.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.18% in the past 14 days, which was lower than the 114.14% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.0545, while its 200-day Moving Average is $1.1916. Nevertheless, the first resistance level for the watch stands at $1.1400 in the near term. At $1.2500, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.3200. If the price goes on to break the first support level at $0.9600, it is likely to go to the next support level at $0.8900. The third support level lies at $0.7800 if the price breaches the second support level.

Genetic Technologies Limited (NASDAQ: GENE) Key Stats

The company with the Market Capitalisation of 24.28 million has total of 19,236K Shares Outstanding. Its annual sales at the moment are 4,930 K in contrast with the sum of -5,170 K annual income. Company’s last quarter sales were recorded 3,331 K and last quarter income was -2,502 K.